---
edited: 2024-03-02
tags:
  - biochemistry
---
### Sources
- Ergocalciferol (D2)
- Cholecalciferol (D3)
	- Synthesized in the skin (stratum basale) when exposed to UV light
	- Fortified foods (e.g., milk, breakfast cereals, formula), fatty fish (liver), egg yolks, plants
### Activation
![[Vitamin_D_activation_and_rickets.jpg]]
- Both are Autosomal recessive 

|                   | Vitamin D-dependent rickets type 1                                                                                                                          | Vitamin D-dependent rickets type 2                                                                                                                                |
| ----------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Pathophysiology   | Autosomal recessive mutation in the 25-hydroxyvitamin-D-1α-hydroxylase gene                                                                                 | Autosomal recessive mutation in the vitamin D receptor gene                                                                                                       |
|                   | Leads to impaired conversion of inactive vitamin D to the active form, 1,25‑dihydroxyvitamin D3 (calcitriol)                                                | Causes end-organ resistance to vitamin D                                                                                                                          |
| Clinical Features | Early onset of rickets (in infancy), Muscle weakness, Growth faltering, Hypotonia, Pathological fractures                                                   | Early onset of rickets (in infancy), Growth faltering, Alopecia                                                                                                   |
| Diagnostics       | Normal or elevated plasma 25-OH, Low or undetectable 1,25(OH)<sub>2</sub>D, Hypocalcemia, hypophosphatemia, and elevated ALP, Elevated parathyroid hormones | Normal or elevated plasma 25-OH, **Extremely elevated plasma 1,25(OH)<sub>2</sub>D**, Hypocalcemia, hypophosphatemia, elevated ALP, Elevated parathyroid hormones |
| Treatment         | Calcitriol supplementation                                                                                                                                  | Very high-dose vitamin D therapy, Refractory disease: elemental calcium                                                                                           |
### Causes of impaired activation
Here's the information tabulated:

| Causes                                                            | Mechanism                                                                                                                                                                          |
| ----------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Liver disease (e.g., cirrhosis)                                   |                                                                                                                                                                                    |
| Chronic kidney disease                                            | Impaired 1α-hydroxylation by the kidneys                                                                                                                                           |
| Hypoparathyroidism                                                | PTH is required to stimulate 1α-hydroxylation by the kidneys.                                                                                                                      |
| Vitamin D-dependent rickets type 1                                |                                                                                                                                                                                    |
| Granulomatous diseases, lymphoma, and primary hyperparathyroidism | These conditions are associated with increased conversion of 25-hydroxy vitamin D to 1,25-hydroxy vitamin D. Other mechanisms may also be involved in primary hyperparathyroidism. |
| cytochrome P450 modulators                                        | Cytochrome P450 inducers can induce the catabolism of active forms of vitamin D.                                                                                                   |
| Anticonvulsants: p                                                | henytoin, carbamazepine, phenobarbital                                                                                                                                             |
| Antimicrobials:                                                   | rifampin, HAART, antifungals                                                                                                                                                       |
| Glucocorticoids                                                   |                                                                                                                                                                                    |
| Cholestyramine                                                    |                                                                                                                                                                                    |
